Consensus ICU Medical, Inc.

Equities

ICUI

US44930G1076

Delayed Nasdaq 04:30:01 2024-03-28 pm EDT 5-day change 1st Jan Change
107.3 USD +4.31% Intraday chart for ICU Medical, Inc. +8.93% +7.60%

Evolution of the average Target Price on ICU Medical, Inc.

Price target over the last 5 years

History of analyst recommendation changes

41.oQGmXlw9QU8UMnnMqomurM28RjKiBLJI0gS23iB420E.xXHMAQ1YLnlgCx-p8viZwviJA2DGd4EK4kvuhlIdmDPGV5cVNgxsIEwHNA~a3ff2d56cc6da35fe7e3b00c64fcaf66
KeyBanc Adjusts Price Target on ICU Medical to $136 From $134, Maintains Overweight Rating MT
CL King Starts ICU Medical With Buy Rating, $110 Price Target MT
Keybanc Adjusts Price Target on ICU Medical to $216 From $200, Keeps Overweight Rating MT
Raymond James Downgrades ICU Medical to Market Perform From Outperform MT
Raymond James Adjusts ICU Medical's Price Target to $190 from $208, Keeps Outperform Rating MT
KeyBanc Adjusts ICU Medical's Price Target to $225 from $230, Keeps Overweight Rating MT
Raymond James Adjusts Price Target on ICU Medical to $208 From $235, Keeps Outperform Rating MT
KeyBanc Adjusts Price Target on ICU Medical to $230 From $265, Reiterates Overweight Rating MT
CJS Securities Adjusts ICU Medical Price Target to $275 From $300, Maintains Market Outperform Rating MT
Raymond James Lowers ICU Medical's Price Target to $235 From $265, Outperform Rating Kept MT
KeyBanc Lowers ICU Medical's Price Target to $265 From $280, Overweight Rating Kept MT
Raymond James Adjusts ICU Medical's Price Target to $265 from $286, Maintains Outperform Rating MT
S&P Maintains Smiths Ratings After $2.7 Billion Medical Arm Sale; Outlook Stable MT
ICU MEDICAL : KeyBanc Adjusts Price Target on ICU Medical to $280 from $302, Keep Overweight Rating MT
ICU MEDICAL : Raymond James Adjusts ICU Medical's Price Target to $286 from $220, Keeps Outperform Rating MT
ICU MEDICAL : KeyBanc Adjusts ICU Medical's Price Target to $302 from $225, Keeps Overweight Rating MT
ICU MEDICAL : KeyBanc Adjusts ICU Medical's Price Target to $225 From $236, Keeps Overweight Rating MT
ICU MEDICAL : Raymond James Adjusts Price Target on ICU Medical to $220 From $245, Maintains Outperform Rating MT
ICU MEDICAL : Raymond James Adjusts Price Target on ICU Medical to $245 From $235, Maintains Outperform Rating MT
ICU MEDICAL : Raymond James Adjusts ICU Medical's Price Target to $235 From $210, Keeps Outperform Rating MT
ICU MEDICAL : KeyBanc Adjusts ICU Medical's Price Target to $236 From $222, Maintains Overweight Rating MT
ICU MEDICAL : KeyBanc Adjusts ICU Medical's Price Target to $222 from $218, Keeps Overweight Rating MT
ICU Medical, Inc. Reports Unaudited Consolidated Earnings Results for the Second Quarter and Six Months Ended June 30, 2018; Revises Earnings Guidance for the Full Year 2018 and Provides Tax Rate Guidance for the Second Half of 2018 CI
ICU Medical, Inc. Announces Unaudited Consolidated Financial Results for the Third Quarter and Nine Months Ended September 30, 2016; Provides Earnings Guidance for the Full Year of Fiscal 2016 and Tax Rate Guidance for the Fourth Quarter 2016 and Earnings Guidance for the Year 2018 CI
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
5
Last Close Price
107.3 USD
Average target price
142.2 USD
Spread / Average Target
+32.55%
High Price Target
161 USD
Spread / Highest target
+50.02%
Low Price Target
135 USD
Spread / Lowest Target
+25.79%

Consensus detail

Consensus revision (last 18 months)

Analysts covering ICU Medical, Inc.

KeyBanc Capital Markets
CL King
Raymond James
CJS Securities
Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings